Registration Dossier

Administrative data

Description of key information

The key study for acute oral toxicity reports an LD50 value of >5000 mg/kg in rat (Kern 1998; rel 1). The acute dermal key study reports an LD50 value of >2000 mg/kg (Wilmot 1998; rel 1).

Key value for chemical safety assessment

Additional information

The most recent and high reliability information weas assigned as key studies. The data for acute inhalation toxicity was waived on the premise that high reliability data were available via the oral and dermal routes, in accordance with current REACH requirements, Section 8.5.2 in Annex VIII. Furthermore, based on the information on other alcohols across category, the LC50 for inhalation toxicity is expected to be greater than the substantially saturated vapour concentration.

In addition to the existing key studies for acute oral and dermal toxicity, high reliability supporting studies were also available which are in accordance with the key findings.

In some cases the CAS and chemical identity stated refer to SDA nomenclature for this substance. In REACH substance identification it is necessary to be more specific as to the chain lengths present. Full details may be found in the CSR.

Justification for classification or non-classification

Acute toxicity tests of the tested material (C16 -17 linear and branched) do not indicate any potential hazard for acute, dermal or inhalation toxicity. Tests on similar substances included in this category are also supportive of these results; which do not warrant classification for any acute toxicity endpoint under DSD or GHS criteria. The substance is therefore not classified for acute toxicity in accordance with EC regulation 1272/2008.